 Home > Medical News >

Medical Research Articles

FDA accelerates approval of new indications for targeted cancer drug Venetoxta

 Time of Update: 2020-06-10

seysara side effects azithromycin dose pneumonia ninlaro side effects blood plasma function anti emesis drugs

, AbbVie and partner Roche announced that the Authority of the of food and drugs (http:// ( FDA (http:// ) has accelerated the approval of a new indication of the anti-cancer drug Venetoxta, a l
FDA approves Zulresso for use in treatment of postpartum depression

 Time of Update: 2020-06-10

balance control fda approved products cancer risk assessment gut depression www myblock com

today, the FDA's (http:// announced that it has approved the listing of, a development by SAGE Therapeutics http:// , to treat patients with postpartum depression (PPD) this therapy will be in
Vimpat two-size tablets have been approved in Japan for treatment of partial seizure epilepsy in pediatrics 4 years and older

 Time of Update: 2020-06-10

program januvia drug class amino acids hair farxiga drug class drug product

recently, Belgian Pharmaceutical (http:// giant UCB Japan sub- company (http:// UCB Japan Co and First Third Pharmaceuticals announced that The Vimpat (lacosamide, lacoamide) 50mg and 100mg ta
Cinda Bio-Innovative Oncology Drug Dabershu ® Joint IBI305 clinical study for first-line hepatocellular carcinoma completes first patient administration

 Time of Update: 2020-06-10

cell acute lymphoblastic lymphoma hiv 1 antibody anti vertigo solid state society zinc anti inflammatory

Today, Cinda Bio Pharmaceutical (http:// (Hong Kong Stock Exchange Code: 01801) announced that the innovative oncology drug (http:// Dabo shu ® (recombinant whole human source anti-PD-1 monocl
Alyscon and Mersa jointly developed the research drug selumetinib has been awarded an FDA-issued breakthrough therapy

 Time of Update: 2020-06-10

2 3 dihydroxypropanal year protein 20 drinks schizophrenia clinical trials pai 1 mutation

incidence is about 1 case per 34,000 newborns, neurofibromatosis type 1 (NF1), a rare, incurable genetic disease NF1 is caused by a mutation in the NF1 gene of synthetic (http:// neurofibromin Th
FDA grants CTX001 fast-track eligibility for blood transfusion-dependent beta thalassemia

 Time of Update: 2020-06-10

morgellons disease treatment human blood smear fda food registration beta amyloid protein host cell protein

recently, gene editing (http:// CRISPR Therapeutics and partner Vertex Pharmaceutical (http:// announced that the U.S Food and Medicines (http:// Administration ( FDA (http:// has granted
Skyland Bio's innovative all-human monoclonal antibody TJC4 obtains FDA clinical trial license

 Time of Update: 2020-06-10

mde drug fda iso 13485 ketamine clinical trials cancer drug resistance drug disease

Skyland Biotech (Shanghai) Limited Company (http:// ("Skyland Bio") announced that its self-developed innovative all-human monoclonal antibody TJC4 for CD47 targets was licensed by the u.S Food
Health Canada approves Abbvie Skyrizi for treatment of adult patients with psoriasis

 Time of Update: 2020-06-10

treatment myrbetriq drug naproxen drug interactions what type drug lyrica hcv drug interactions

Recently, Us biotech giant AbbVie announced that Health Canada has approved Skyrizitoto for treatment of adult patients with moderate to severe plaque psoriasis suitable for systemic therapy or phot
FDA approves new treatments Dovato and lamiff for treatment of adult HIV-1 patients

 Time of Update: 2020-06-10

hiv treatment drugs keppra drug interactions blood sample tube single use bioreactor marijuana drug interactions

recently, the United States The FDA's (http:// announced the approval of the new treatment dovato and lamivudine, which is expected to be the first two drug (http:// combination of drugs to tr
European Commission approves Pfizer-beva monobiosimilar ZIRABEV ™ for treatment of multiple cancers

 Time of Update: 2020-06-10

fisher clinical services food drug interactions list apixaban generic name lidocaine drug class potassium generic name

recently, Pfizer announced (http:// that the European Commission (EC) has approved the use of beva monobiothire pharmaceutical (http:// ZIRABAEV ™ for the treatment of a variety of cancers, su
TG Therapeutics gets FDA-issued breakthrough treatment in new drug umbralisib (TGR-1202)

 Time of Update: 2020-06-10

anti actin antibody primary cell line anti la antibody 3 8 barb anti parietal antibody

MZL, which begins to grow in the edge region of lymphatic tissue, is an inert lymphoma that progresses and spreads slowly MZL is the third most common B-cell non-Hodgkin lymphoma (non-Hodgkin lympho
FDA approves application for license for complementary biologics at Romiplostim

 Time of Update: 2020-06-10

2 1 simplified treatments topotecan adverse effects anemia natural treatment 1 2 epoxyhexane

recently, biotech giant Amgen announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has approved nplate's (http:// application for a supplementary biologic license (sBLA)
FDA grants CymaBay Therapeutics research drug Seladelpar breakthrough therapy

 Time of Update: 2020-06-10

mailstack global email antibiotics periodontal disease treatment proof concept study cod liver oil phase contrast microscopy

primary bile ductitis (PBC) is a serious and potentially life-threatening liver autoimmune disease characterized by bile siltation and the accumulation of toxic bile acids The accompanying inflammat
European Commission approves expansion of allergy to blinatumomab monodruga treatment

 Time of Update: 2020-06-10

what kills parkinson patients what all cells all therapy pathogen positive bubble study

recently, the US biotech giant Amgen BiTE immunotherapy blinatumomab on EU regulation spout European Commission (EC) has approved the expansion of Blincyto monotherapy for the treatment of adult pa
ViiV Health's compound new drug Juluca is approved by Japan's Ministry of Health, Labour and Welfare

 Time of Update: 2020-06-10

parkinson's treatment drug hiv rna new lifeline skin use stop leak 1 2 dichlorobenzene

recently, ViiV Health (http:// announced that its two-in-one new drug (http:// Juluca (dolutegravir/rilpivirine, dotiravir/ripivirin, 50mg/25mg tablets) has been approved by the Ministry of H
China's approved slow hepatitis B drug, Wei lide ® officially listed

 Time of Update: 2020-06-10

phentermine drug interactions aetna prescription drug plan lipitor drug aleria drug 3 1 fade

With the increase of hepatitis B vaccination coverage, the number of hepatitis B infection in China has decreased significantly However, the status quo of diagnosis and treatment remains bleak 1/3 p
Uber obtains license for imported drug with anti-epileptic drug Vimpat

 Time of Update: 2020-06-10

fentanyl drug class anti nmda receptor what antagonist drug what function cells ipratropium drug class

recently, the Belgian Pharmaceutical (http:// giant UCB announced that the company (http:// has obtained an imported drug license (IDL) of the anti-epileptic drug from The national drug (ht
Legendary bio-multiple myeloma drug JNJ-68284528 is eligible for EMA priority drug recognition

 Time of Update: 2020-06-10

drug monograph example senokot drug bms products radio company onlyfa com

recently, Kingsley Biotech Limited Company (http:// announced that its subsidiary Legendary Bio and Johnson Pharmaceuticals (http:// subsidiary, Janssen Pharmaceuticals, have jointly developed
FDA grants Eiger's breakthrough drug for hepatitis D infection

 Time of Update: 2020-06-10

levels protein finasteride drug class drug profile benadryl drug test drug website

, eiger (http:// announced that the u.S Food and Drug (http:// Administration ( FDA (http:// ) has granted lonafarnib a breakthrough drug (BTD) for the treatment of hepatitis D virus (HDV) in
FDA Grants BBT-877 For Orphan Drug For Iapathic Pulmonary Fibrosis

 Time of Update: 2020-06-10

chantix drug class food drug administration jobs drug molecules ketorolac drug class pathophysiology ulcerative colitis

recently, South Korea's Bridge Bios company (http:// announced that the u.S Food and Drug (http:// Administration ( FDA (http:// ) has granted BBT-877 treatment for iacotic pulmonary fibrosis

Go to Page

Medical Research Articles

FDA accelerates approval of new indications for targeted cancer drug Venetoxta

FDA approves Zulresso for use in treatment of postpartum depression

Vimpat two-size tablets have been approved in Japan for treatment of partial seizure epilepsy in pediatrics 4 years and older

Cinda Bio-Innovative Oncology Drug Dabershu ® Joint IBI305 clinical study for first-line hepatocellular carcinoma completes first patient administration

Alyscon and Mersa jointly developed the research drug selumetinib has been awarded an FDA-issued breakthrough therapy

FDA grants CTX001 fast-track eligibility for blood transfusion-dependent beta thalassemia

Skyland Bio's innovative all-human monoclonal antibody TJC4 obtains FDA clinical trial license

Health Canada approves Abbvie Skyrizi for treatment of adult patients with psoriasis

FDA approves new treatments Dovato and lamiff for treatment of adult HIV-1 patients

European Commission approves Pfizer-beva monobiosimilar ZIRABEV ™ for treatment of multiple cancers

TG Therapeutics gets FDA-issued breakthrough treatment in new drug umbralisib (TGR-1202)

FDA approves application for license for complementary biologics at Romiplostim

FDA grants CymaBay Therapeutics research drug Seladelpar breakthrough therapy

European Commission approves expansion of allergy to blinatumomab monodruga treatment

ViiV Health's compound new drug Juluca is approved by Japan's Ministry of Health, Labour and Welfare

China's approved slow hepatitis B drug, Wei lide ® officially listed

Uber obtains license for imported drug with anti-epileptic drug Vimpat

Legendary bio-multiple myeloma drug JNJ-68284528 is eligible for EMA priority drug recognition

FDA grants Eiger's breakthrough drug for hepatitis D infection

FDA Grants BBT-877 For Orphan Drug For Iapathic Pulmonary Fibrosis